Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (391-400 of 752) with videos related to

Pageof 76
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2020
Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trialMarie Hauguel-Moreau, Olvier Barthélémy, Serdar Farhan, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 25, 2011
Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid arteryAlexandra Schwarzmaier-D'Assie, Noemi Nyolczas, Rayyan Hemetsberger, et al.
Journal of Cellular and Molecular Medicine|March 21, 2009
The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblastsKathrin Rychli, Christoph Kaun, Philipp J Hohensinner, et al.
Atherosclerosis|September 17, 2010
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failureBernhard Richter, Kathrin Rychli, Philipp J Hohensinner, et al.
Wiener Klinische Wochenschrift|September 15, 2016
Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization : A real world experienceMiklos Rohla, Ioannis Tentzeris, Matthias K Freynhofer, et al.
Circulation. Cardiovascular Interventions|September 5, 2020
Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK TrialCan Martin Sag, Uwe Zeymer, Taoufik Ouarrak, et al.
Scandinavian Journal of Medicine & Science in Sports|November 3, 2020
Effect of marathon and ultra-marathon on inflammation and iron homeostasisChristoph C Kaufmann, Claudia Wegberger, Maximilian Tscharre, et al.
European Heart Journal. Acute Cardiovascular Care|April 12, 2023
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shockUwe Zeymer, Christiane Lober, Stephan Richter, et al.
Journal of the American College of Cardiology|December 6, 2023
Research Priorities in Critical Care Cardiology: JACC Expert PanelP Elliott Miller, Kurt Huber, Erin A Bohula, et al.
International Journal of Cardiology|December 16, 2014
The Austrian transcatheter aortic valve implantation (TAVI) Registry--3 years' dataDavid Zweiker, Robert Maier, Gudrun Lamm, et al.
Pageof 76

Showing results (391-400 of 752) with videos related to

Sort By:
Pageof 76
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 7, 2020
Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trialMarie Hauguel-Moreau, Olvier Barthélémy, Serdar Farhan, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|August 25, 2011
Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid arteryAlexandra Schwarzmaier-D'Assie, Noemi Nyolczas, Rayyan Hemetsberger, et al.
Journal of Cellular and Molecular Medicine|March 21, 2009
The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblastsKathrin Rychli, Christoph Kaun, Philipp J Hohensinner, et al.
Atherosclerosis|September 17, 2010
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failureBernhard Richter, Kathrin Rychli, Philipp J Hohensinner, et al.
Wiener Klinische Wochenschrift|September 15, 2016
Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization : A real world experienceMiklos Rohla, Ioannis Tentzeris, Matthias K Freynhofer, et al.
Circulation. Cardiovascular Interventions|September 5, 2020
Effects of ON-Hours Versus OFF-Hours Admission on Outcome in Patients With Myocardial Infarction and Cardiogenic Shock: Results From the CULPRIT-SHOCK TrialCan Martin Sag, Uwe Zeymer, Taoufik Ouarrak, et al.
Scandinavian Journal of Medicine & Science in Sports|November 3, 2020
Effect of marathon and ultra-marathon on inflammation and iron homeostasisChristoph C Kaufmann, Claudia Wegberger, Maximilian Tscharre, et al.
European Heart Journal. Acute Cardiovascular Care|April 12, 2023
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shockUwe Zeymer, Christiane Lober, Stephan Richter, et al.
Journal of the American College of Cardiology|December 6, 2023
Research Priorities in Critical Care Cardiology: JACC Expert PanelP Elliott Miller, Kurt Huber, Erin A Bohula, et al.
International Journal of Cardiology|December 16, 2014
The Austrian transcatheter aortic valve implantation (TAVI) Registry--3 years' dataDavid Zweiker, Robert Maier, Gudrun Lamm, et al.
Pageof 76